Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MAIA Biotechnology, Inc. (MAIA) just unveiled an announcement.
Starting April 1, 2024, Jeffrey Himmelreich’s employment agreement will see his base salary raised to $250,000, with his target annual bonus climbing to 25% of his base salary, reflecting a substantial increase in his compensation package.
Find detailed analytics on MAIA stock on TipRanks’ Stock Analysis page.
